In this article, the characterization, synthesis, as well as the photocatalysis dye degradation performance of two novel silver(I) coordination polymers, namely, [Ag(L)(Hbdc)]_n (1, L = 1,4-Bis(5,6-dimethylbenzimidazol-1-yl)butane, H₂bdc = 1,4-Benzenedicarboxylic acid) and [Ag₂(L)(hip)]_n (2, H₂hip = 5-Hydroxyisophthalic acid), were investigated. Fascinatingly, the photocatalytic performance of Complexes 1 and 2 have been investigated, wherein Complex 2 is considered an excellent photocatalyst for degrading Rhodamine B/methyl violet/methylene blue mixed organic dyes. Furthermore, the treatment activities of Complexes 1 and 2 on Tic disorder (TD) were assessed when used with haloperidol, and biochemical studies were conducted to reveal the mechanism in detail. Initially, the enzyme-linked immunosorbent assay was carried out to determine the dopamine and high vanillic acid contents in the striatum of the TD animal model. Subsequently, the reverse transcription-polymerase chain reaction was utilized to determine the relative expression of dopamine 1 and 2 receptor.

在本文中，两种新型银（I）配位聚合物[Ag（L）（Hbdc）] _n（1，L = 1,4-Bis（）的表征，合成以及光催化染料的降解性能研究了5,6-二甲基苯并咪唑-1-基）丁烷，H ₂ bdc = 1,4-苯二甲酸）和[Ag ₂（L）（hip）] _n（2，H ₂ hip = 5-羟基间苯二甲酸） 。令人着迷的是，研究了配合物1和2的光催化性能，其中配合物2被认为是降解若丹明B /甲基紫/亚甲基蓝混合有机染料的极好光催化剂。此外，与氟哌啶醇一起使用时，评估了复合物1和2对抽动症（TD）的治疗活性，并进行了生化研究以详细揭示其机制。最初，进行了酶联免疫吸附测定，以确定TD动物模型纹状体中的多巴胺和高香草酸含量。随后，利用逆转录聚合酶链反应确定多巴胺1和2受体的相对表达。